Horizon Therapeutics
In David Abrams's portfolio · Abrams Capital Management
Ticker HZNP
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Abrams Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2023 | Sell | 0 | |
| Q2 2023 | Buy | 890,993 | 2.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.